Beta-Amlyoid 1–42 and Tau-Protein in Cerebrospinal Fluid of Patients with Parkinson’s Disease Dementia

Publisher： Karger

E-ISSN： 1421-9824|22|3|200-208

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.22, Iss.3, 2006-08, pp. : 200-208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cerebrospinal Fluid Phospho-Tau, Total Tau and β-Amyloid1–42 in the Differentiation between Alzheimer’s Disease and Vascular Dementia

By  

Dementia and Geriatric Cognitive Disorders, Vol. 14, Iss. 4, 2002-11 ,pp. : 183-190

Karger

Access to resources Recommend Favorite

Tau Protein, Aβ42 and S-100B Protein in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies

By  

Dementia and Geriatric Cognitive Disorders, Vol. 19, Iss. 2-3, 2005-02 ,pp. : 164-170

Karger

Access to resources Recommend Favorite

Follow-Up Investigations of Tau Protein and S-100B Levels in Cerebrospinal Fluid of Patients with Creutzfeldt-Jakob Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 19, Iss. 5-6, 2005-04 ,pp. : 376-382

Karger

Access to resources Recommend Favorite

The Cerebrospinal Fluid Level of Glial Fibrillary Acidic Protein Is Increased in Cerebrospinal Fluid from Alzheimer’s Disease Patients and Correlates with Severity of Dementia

By  

European Neurology, Vol. 46, Iss. 1, 2001-07 ,pp. : 35-38

Karger

Access to resources Recommend Favorite

Brain Metabolic Correlates of Cerebrospinal Fluid Beta-Amyloid 42 and Tau in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 27, Iss. 5, 2009-05 ,pp. : 474-480

Karger

Access to resources Recommend Favorite